Financials (USD)
Sales 2024 * | 117M | Sales 2025 * | 130M | Capitalization | 86.51M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.74 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.66 x |
P/E ratio 2024 * |
-7.58
x | P/E ratio 2025 * |
182
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.24% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 19-01-31 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 19-06-30 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 03-10-31 |
James Tyree
BRD | Director/Board Member | 71 | 16-09-30 |
William McKee
BRD | Director/Board Member | 62 | 17-02-28 |
1st Jan change | Capi. | |
---|---|---|
+27.92% | 672B | |
+27.10% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+7.42% | 217B | |
+6.00% | 199B | |
-8.79% | 204B | |
-8.58% | 149B |